LENZ Therapeutics, Inc. (GRPH) Nonoperating Income (Expense) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
LENZ Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
  • LENZ Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$560 K, a 937% decline year-over-year.
  • LENZ Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $10 M, a 128% increase year-over-year.
  • LENZ Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $10.5 M, a 130% increase from 2022.
  • LENZ Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.59 M.
  • LENZ Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$10.3 M, a 81.2% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10 M -$560 K -$506 K -937% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $10.5 M $5.21 M +$3.06 M +142% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $7.49 M $2.54 M +$1.07 M +72.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $6.42 M $2.85 M +$2.01 M +239% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.41 M -$54 K -$177 K -144% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $4.59 M $2.15 M +$2.14 M +21420% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $2.45 M $1.47 M +$1.46 M +14620% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $983 K $840 K +$836 K +20900% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $147 K $123 K +$10.5 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$10.3 M $10 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $10 K -$370 K -97.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $4 K +$24 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$10.3 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $380 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$20 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.